/ CompletedNot Applicable [Translation] Bioequivalence study of clarithromycin soft capsules in Chinese healthy adult volunteers
考察单剂量口服试验制剂克拉霉素软胶囊(珠海金鸿药业股份有限公司,规格0.25g/粒)的人体内药代动力学,并以已上市的克拉霉素片(克拉仙,意大利雅培制药有限公司,0.25g/片)为标准参比制剂,评价试验制剂与参比制剂的生物等效性。为该药的注册和上市应用提供依据。
[Translation] The pharmacokinetics of a single-dose oral test preparation, clarithromycin soft capsules (Zhuhai Jinhong Pharmaceutical Co., Ltd., specification 0.25g/capsule), were investigated in humans, and the bioequivalence of the test preparation and the reference preparation was evaluated using the marketed clarithromycin tablets (Clarithromycin, Abbott Pharmaceuticals Co., Ltd., Italy, 0.25g/tablet) as the standard reference preparation, providing a basis for the registration and marketing application of the drug.
100 Clinical Results associated with China Meheco Great Wall Pharma Co. Ltd.
0 Patents (Medical) associated with China Meheco Great Wall Pharma Co. Ltd.
100 Deals associated with China Meheco Great Wall Pharma Co. Ltd.
100 Translational Medicine associated with China Meheco Great Wall Pharma Co. Ltd.